China Valve Registry Study-1 | NCT02623907 | Trialant

China Valve Registry Study-1 | NCT02623907 | Trialant

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Cardiovascular (CV) death or hospitalization for heart failure (HF)	from date of enrollment until the date of first documented HF or date of death from any cause, whichever came first, up to 36 months	36 months
Surgical or transcatheter aortic valve replacement	from date of enrollment until the date of surgical or transcatheter aortic valve replacement, whichever came first, up to 36 months	36 months

Secondary Outcomes

Measure	Description	Time Frame
Number of all-cause mortality		from date of enrollment until the date of death for any-cause, up to 36 months
Number of patients developing major cardiovascular and cerebral events (MACCE)		36 moths

Condition Browse Module